CompletedPhase 3NCT03822754

A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sinovac Biotech Co., Ltd
Principal Investigator
Yuemei Hu
Jiangsu Provincial Center for Disease Control and Prevention
Intervention
sIPV-bOPV-bOPV vaccination schedule(biological)
Enrollment
240 target
Eligibility
All sexes
Timeline
2018 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03822754 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials